Baicheng Pharmaceuticals (301096.SZ): The innovative drug BIOS-0625 tablets have obtained the clinical trial approval notification.

Zh tng cijng APP news, Bi chng yyo (301096.SZ) issued an announcement. The company recently learned that its self-developed innovative drug BIOS-0625 tablets has obtained the clinical trial approval notification from the National Medical Products Administration (NMPA).